Can I increase my Wegovy dose early — and who actually decides?

The myth: moving up faster means losing weight faster

It feels logical. If nausea has settled by week two and the scales have barely shifted, why wait another fortnight? The assumption is that the therapeutic effect lives at the higher dose and the schedule is just a formality. That is not how semaglutide works.

The titration exists because the gastrointestinal system needs time to adapt to GLP-1 receptor agonism. Gastric emptying slows, appetite signals change, and the lining of the gut is responding to a medicine it has never encountered before. Starting at 0.25mg and moving up in stages is what keeps those effects manageable. Skipping a step does not deliver more weight loss sooner, it delivers a much higher chance of severe nausea, vomiting and diarrhoea that can force you off treatment entirely. Stopping prematurely is the outcome the schedule is designed to prevent.

The NHS's semaglutide guidance is unambiguous: dose increases are made by a healthcare professional on an individual basis. The schedule on your prescription is not a suggestion.

What the licensed schedule actually says, and where 7.2mg fits

The standard Wegovy maintenance pathway runs 0.25mg, then 0.5mg, then 1.0mg, then 1.7mg, then 2.4mg, each step roughly four weeks apart as directed by your prescriber. The 2.4mg dose was, until recently, the ceiling. The MHRA approved a 7.2mg maintenance dose in early 2026, with a dedicated single-dose pen confirmed in April 2026, though the journey to that level still begins at 0.25mg. You can read more about the full range on our Wegovy doses overview.

Each strength exists because a proportion of patients do not tolerate a given dose well and stay there longer, or step back temporarily. The prescriber's job is to track that. If you have reached 2.4mg and are considering whether a higher dose is relevant, that is a clinical conversation, not something you can initiate by taking pens closer together. The question of how Wegovy dose increases work in practice covers that clinical framework in more detail.

A note worth making: semaglutide also exists as Ozempic and Rybelsus, both licensed for type 2 diabetes, not weight management. These are different products on different dose schedules and should never be used interchangeably with Wegovy.

The real risk of rushing a dose increase

The most commonly reported side effects of semaglutide are gastrointestinal. Nausea, vomiting, diarrhoea, constipation and reflux are all more likely after a dose step up, and most settle within a week or two as the body adjusts. If you move up before that adjustment has happened, you are stacking a new dose on top of a system that has not finished adapting to the previous one.

There is also a practical consequence. Severe GI side effects are the most frequent reason patients stop weight-loss injections early. Every clinical trial that measured Wegovy's results (including the STEP 1 trial published in the New England Journal of Medicine, which showed around 15% average weight reduction over 68 weeks) was conducted with the standard titration schedule followed, not compressed. The outcomes attributed to the medicine assume the protocol was respected.

If side effects have already been difficult for you, our guide to the 0.5mg dose and its effects may help you understand what is typical at the early stages and when it is worth raising with your prescriber.

What a legitimate dose review looks like at nume

At nume, every repeat order is reviewed by a GPhC-registered Independent Prescriber before it is dispensed. That review is not automated. A real clinician looks at where you are in the schedule, what you have reported about tolerability, and whether a dose change is appropriate. For patients transferring from another provider and requesting an accelerated step, we ask for evidence of their current treatment, not because we are being obstructive, but because dispensing a higher dose without clinical confidence is not something a responsible pharmacy does.

If you think you are ready to move up, the right move is to tell your prescriber at your next review, or to contact the aftercare team with your concerns. The same applies if you want to consider whether the newer 7.2mg pathway might be relevant to you, which our guide to Wegovy dose increases covers in plain terms.

The process at nume, sorry, at nume

To be clear about how treatment works with us: your consultation is reviewed the same day it is submitted by a named prescriber. If you are clinically suitable and approved before midday on a working day, your treatment is dispatched that day and delivered free the next working day by DPD, in plain packaging. You can see the full picture on our Wegovy treatment page.

Pricing for Wegovy varies by dose and provider. If the cost of each titration step is a factor in your thinking, our Wegovy pricing page sets out what is included in a single transparent price at nume. One thing worth knowing: a clinically supervised programme that keeps you on treatment safely will almost always deliver better long-term results than a cheaper or faster route that leads to stopping early.